HOB Biotech Group Corp Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.019x

HOB Biotech Group Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, HOB Biotech Group Corp Ltd (688656) has a cash flow conversion efficiency ratio of 0.019x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.28 Million ≈ $2.24 Million USD) by net assets (CN¥820.01 Million ≈ $119.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of HOB Biotech Group Corp Ltd (2016–2025)

Cash flow conversion efficiency of HOB Biotech Group Corp Ltd from 2016 to 2025. This chart illustrates how HOB Biotech Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688656 stock price and chart for real-time trading data and today's change.

HOB Biotech Group Corp Ltd Cash Flow Conversion Ratio Explained

HOB Biotech Group Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

HOB Biotech Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HOB Biotech Group Corp Ltd ranked by their cash flow conversion efficiency. Also see HOB Biotech Group Corp Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Wah Lee Industrial Corp TW:3010	0.015x
McEwen Mining Inc. TO:MUX	0.019x
Scandinavian Tobacco Group A/S CO:STG	0.017x
Fortrea Holdings Inc. NASDAQ:FTRE	0.149x
Arcadyan Technology Corp TW:3596	-0.503x
TAG Colonia-Immobilien AG HM:KBU	N/A
Far Eastern Department Stores Ltd TW:2903	0.001x
Insigma SHG:600797	0.030x

Annual Cash Flow Conversion Efficiency for HOB Biotech Group Corp Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of HOB Biotech Group Corp Ltd from 2016 to 2025. Review free cash flow generation of HOB Biotech Group Corp Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥820.01 Million ≈ $119.99 Million	CN¥72.94 Million ≈ $10.67 Million	0.089x	-28.63%
2024-12-31	CN¥812.14 Million ≈ $118.84 Million	CN¥101.22 Million ≈ $14.81 Million	0.125x	-1.61%
2023-12-31	CN¥810.73 Million ≈ $118.64 Million	CN¥102.69 Million ≈ $15.03 Million	0.127x	+69.36%
2022-12-31	CN¥779.57 Million ≈ $114.08 Million	CN¥58.31 Million ≈ $8.53 Million	0.075x	-45.04%
2021-12-31	CN¥770.00 Million ≈ $112.68 Million	CN¥104.79 Million ≈ $15.33 Million	0.136x	-51.76%
2020-12-31	CN¥206.39 Million ≈ $30.20 Million	CN¥58.22 Million ≈ $8.52 Million	0.282x	-38.44%
2019-12-31	CN¥149.64 Million ≈ $21.90 Million	CN¥68.57 Million ≈ $10.03 Million	0.458x	+31.16%
2018-12-31	CN¥133.12 Million ≈ $19.48 Million	CN¥46.51 Million ≈ $6.81 Million	0.349x	+24.05%
2017-12-31	CN¥79.03 Million ≈ $11.56 Million	CN¥22.26 Million ≈ $3.26 Million	0.282x	+148.76%
2016-12-31	CN¥56.71 Million ≈ $8.30 Million	CN¥6.42 Million ≈ $939.60K	0.113x	--

About HOB Biotech Group Corp Ltd

SHG:688656 China Medical Devices

Market Cap

$948.07 Million

CN¥6.48 Billion CNY

Market Cap Rank

#8806 Global

#2085 in China

Share Price

CN¥102.00

Change (1 day)

-4.66%

52-Week Range

CN¥78.49 - CN¥213.11

All Time High

CN¥213.11